MSD to push for approval of HIV combo after Phase III success
Merck & Co (MSD) is looking to file for approval of
its human immunodeficiency virus (HIV) treatment after two positive
Phase III trial readouts. |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.